Detalhe da pesquisa
1.
IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma.
Gastroenterology
; 162(7): 2047-2062, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35271824
2.
Pancreatic Cancer's PD1-Roadblock: When T-Cell Reinvigoration Is Not Enough.
Clin Cancer Res
; 30(3): 474-476, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38038687
3.
Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer.
Cancer Discov
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683144
4.
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer.
Cancer Discov
; : OF1-OF32, 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683683
5.
Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer.
Cancer Immunol Res
; 11(8): 1055-1067, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37229629
6.
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity.
Cancer Cell
; 41(6): 1073-1090.e12, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37236195
7.
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy.
J Exp Med
; 220(6)2023 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951731
8.
Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade.
Cancer Discov
; 12(12): 2774-2799, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36165893